ArticleOncotarget2014

The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma.

Emmy D G Fleuren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.